BlueBee serves diagnostic and research assay manufacturers with fit-for-purpose data solutions that extend the go-to-market strategy for the assay manufacturer in brand and desired global data compliance.
BlueBee also directly serves high-throughput, routine testing laboratories such as clinical labs or high-throughput genomics service centers with on demand scalability and a clinical-grade solution for standardization and efficiency. Cross-functional teams of pharma, clinical research organizations (CROs), clinicians, and more involved in routine testing or large projects such as translational or population-scale genomic sequencing, are served by effectively centralizing and managing genomics data processes.
BlueBee uniquely enables the discovery of both genomics and business insights via the delivery of optimized data analysis pipelines through report generation and learning from aggregate data. BlueBee technology employs high-performance computing and secure cloud technologies.
The result is a solution that enables powerful and efficient clinical and research data processing and novel insight generation, from ever-increasing volumes and complexities of genomic data.
BlueBee also directly serves high-throughput, routine testing laboratories such as clinical labs or high-throughput genomics service centers with on demand scalability and a clinical-grade solution for standardization and efficiency. Cross-functional teams of pharma, clinical research organizations (CROs), clinicians, and more involved in routine testing or large projects such as translational or population-scale genomic sequencing, are served by effectively centralizing and managing genomics data processes.
BlueBee uniquely enables the discovery of both genomics and business insights via the delivery of optimized data analysis pipelines through report generation and learning from aggregate data. BlueBee technology employs high-performance computing and secure cloud technologies.
The result is a solution that enables powerful and efficient clinical and research data processing and novel insight generation, from ever-increasing volumes and complexities of genomic data.
Location: Netherlands, South Holland, The Hague
Employees: 11-50
Total raised: $11.4M
Founded date: 2011
Investors 4
| Date | Name | Website |
| - | YES!Delft | yesdelft.c... |
| - | Heran Part... | heranpartn... |
| - | Capricorn ... | capricorn.... |
| - | Korys | korys.be |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.03.2016 | Series A | $11.4M | - |
Mentions in press and media 25
| Date | Title | Description |
| 09.01.2025 | Capricorn Partners secures €51 million for Health-tech Fund II’s first close | Capricorn Partners, headquartered in Leuven, has announced the first close of its Capricorn Health-tech Fund II, raising €51 million to support innovative health technology startups. Capricorn Health-tech Fund II builds upon the success of ... |
| 20.05.2020 | TruGenomix Partners with BlueBee to create the next generation Behavioral Science Data Ecosystem | Rockville, MD and San Mateo, CA USA: 20 May 2020 – The unprecedented COVID-19 crisis has unleashed global emotional trauma that is rapidly evolving into a mental health pandemic within the pandemic. While post-traumatic stress disorder (PTS... |
| 09.10.2019 | BlueBee establishes data center in mainland China, expanding global coverage for its Genomics Data Platform | Rijswijk, The Netherlands: 9 October 2019 – BlueBee, a global bioinformatics solutions provider, has extended data operations to mainland China to serve genomic data processing needs in compliance with The Chinese Ministry of Health and Tec... |
| 19.09.2019 | Menarini Silicon Biosystems launches the MSBiosuite Bioinformatic platform, partners with BlueBee cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows | Bologna, Italy: 19 September 2019 – Menarini Silicon Biosystems today announces the launch of the MSBiosuite, a cloud-based data analysis solution that completes the company workflow* for liquid biopsy and formalin-fixed paraffin embedded (... |
| 09.03.2019 | Bluebee receives Health Data Hosting (HDS) accreditation | Rijswijk, The Netherlands: 6 March 2019 – Bluebee, a global bioinformatics solutions provider, has been awarded the HDS:2018 certification for its Information Security Management System (ISMS). The Hébergeurs de Données de Santé or Health D... |
| 15.06.2018 | Bluebee achieves ISO 13485 Medical Device Quality Standard Certification | Rijswijk, The Netherlands: 15 June 2018 – Bluebee, a global bioinformatics solutions provider, has announced today that it has been awarded the ISO 13485:2016 certification. ISO 13485 is an internationally recognized medical device quality ... |
| 12.06.2018 | Lexogen and Bluebee collaborate to streamline QuantSeq-UMI Sequencing Data Analysis Pipeline | Vienna, Austria and Rijswijk, The Netherlands: 12 June 2018 – Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecu... |
| 08.02.2018 | New England Biolabs and Bluebee partner to deliver an end-to-end data analysis solution for NEBNext direct target enrichment | Rijswijk, The Netherlands and Ipswich, USA: 8 February 2018 – Bluebee, a company driving global genomic data-driven medicine, and New England Biolabs, Inc. (NEB®) have partnered to provide a secure and convenient data processing solution fo... |
| 19.12.2017 | Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint®BluePrint® Breast Cancer Kit to Market | Irvine, USA and Rijswijk, Netherlands: 19 December 2017 – Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, and Bluebee, a company driving global genomic data-driven medicine, have partnered to provide ... |
| 10.11.2017 | Lexogen and Bluebee partner to bring the SLAMseq metabolic RNA sequencing data analysis pipeline to the users | Rijswijk, The Netherlands and Vienna, Austria: 10 November 2017 – Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the... |
Show more